ARAY

ACCURAY INC ARAY

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,694 of 2,925

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$100.92M

Quarter to Jun 30

Net income

$-1.94M

Quarter to Jun 30

Free cash flow

$1.97M

Quarter to Jun 30

Operating margin

5.5%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$17.60M total
Reading the latest SEC filing…

Key Metrics

Revenue

Q4 2026
EDGAR

Net Income

Q4 2026
EDGAR

Operating Margin

Q4 2026
EDGAR

ROIC

Q4 2026
EDGAR

Free Cash Flow

Q4 2026
EDGAR

Debt/Equity

Q4 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ARAY

Earnings Per Share

13fpro.ai/company/ARAY

Loading ratio trend…

About ACCURAY INC (ARAY): stock profile, AI score and financials

ACCURAY INC (ARAY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ARAY at 23.2/100 on a composite quality score built from its SEC filings, placing it at rank #2,694 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (2.4) and revenue growth (13.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 43.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), ACCURAY INC reports quarterly revenue of $100.9M, net income of $-1.9M, an operating margin of 5.5%. ARAY trades on the Nasdaq exchange and files with the SEC under CIK 1138723. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARAY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACCURAY INC directly from SEC EDGAR.

SEC EDGAR: CIK 1138723 →